Navigation Links
Leading researchers and experts gather to discuss latest advancements in drug discovery
Date:1/8/2008

WHO: Society for Biomolecular Sciences (SBS)

WHAT: Latest Findings and Research on Advancements in Drug Discovery and Biotechnology

WHEN: April 6-10, 2008

WHERE: SBS 14th Annual Conference at Americas Center, St. Louis, Missouri

BACKGROUND:

More than 2,500 researchers and professionals in the area of biomolecular science and drug discovery are expected to attend the 14th Annual Conference & Exhibition of the Society for Biomolecular Sciences to discuss advances in biotechnology, challenges and automation solutions in the field. Topics and speakers scheduled for the St. Louis meeting this year include:

  • Methods in phenotypic and mechanistic screening for primary cells and stem cells in drug discovery

  • Latest techniques in targeting the appropriate genes in the human genome sequence to identify novel mechanisms for human disease treatment

  • Development of small molecule anti-cancer agents

  • Label-free detection in high-throughput screening and lead validation

SPECIAL GUEST SPEAKERS:

  • Jonathan D. Gitlin, M.D., Helene B. Roberson Professor of Pediatrics and professor of genetics, Washington University School of Medicine; scientific director of the Childrens Discovery Institute, who will address: Child Health Research in the 21st Century: Obstacles and Opportunities

  • Janet Woodcock, M.D., deputy commissioner, U.S. Food & Drug Administration, who will address: The Promise of Molecular Medicine

  • Jeffrey I. Gordon, M.D., Dr. Robert J. Glaser Distinguished University Professor, Washington University School of Medicine, who will address: Dining in With a Few Trillion Friends: Exploring the Human Gut Microbiota and Microbiome

The meeting will also offer sessions on translational medicine, biomarkers and discovery, and the development of vaccines and monoclonal antibodies.


'/>"/>

Contact: Jennifer Bender
jbender@environics-usa.com
203-325-8772 x17
Society for Biomolecular Sciences
Source:Eurekalert

Page: 1

Related biology news :

1. M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology
2. Leading experts cite poor health and nutrition as major barrier to education in developing world
3. Ossur -- leading orthopedic pioneer - expands network to Asia
4. Leading researchers to reveal comprehensive dos and donts for prostate cancer
5. BIO-key(R) PocketCop(R) Project Leading the Nation According to Televised Report
6. Are current projections of climate change-impacts on biodiversity misleading?
7. Cleveland Clinic leading clinical program to improve early-stage lung cancer detection
8. Leading cause of death in preemies might be controlled by resetting a molecular switch
9. Researchers identify proteins involved in new neurodegenerative syndrome
10. Texas researchers and educators head for Antarctica
11. MGH researchers describe new way to identify, evolve novel enzymes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology: